Experience

• 

  Centro internacional de entrenamiento e investigaciones médicas

  Jan 2005 - Jan 2007

  Researcher assistant scientist

  . Achieved funding for at least 4 research projects in basic science from different sponsors in alliance with national and international Universities, generating knowledge published in 4 indexed journals A1.* Young Investigator / January, 2005 - December, 2005Secured a scholarship in the national scientific training program supported by COLCIENCIAS in a WHO Collaborating Center in Leishmaniasis (CIDEIM) and funded a research project on a problem of public health concern.

• 

  Yale university. department of epidemiology and public health

  Oct 2005 - Dec 2005

  Associated investigator

  Technical execution, results analysis and writing publications and reports of the project: Microarrays for differential gene expression analysis human macrophages of healthy donors in vitro infected with L. Viannia panamensis.

• 

  Fundación universitaria del área andina

  Feb 2007 - Jun 2007

  Teacher

  Teacher of Bases of Investigation, Research Methodology, Research Project I and II and Quantitative Research for students of Food Engineering and Nursing faculties.Methodological advisor of thesis:FEASIBILITY STUDY FOR CREATING A COMPANY OF FROZEN AND CHILLED MASS. Paola AyalaJulieth Toro. 2007.COMESTIBLE FILMS AND BIODEGRABLE PACKAGING.Cristian Mamela and Diana Rodríguez. 2007.

• 

  Centro dermatológico federico lleras acosta e.s.e

  Oct 2011 - Mar 2013

  Teacher of the leishmaniasis virtual module of the course “Sanitary Dermatology”. The course wasorganized by Centro Dermatológico Federico Lleras Acosta E.S.E. in agreement with the Ministry ofHealth of Colombia. The goal of this course was to train health professionals (doctors, nurses, bacteriologists, physiotherapists and social workers) on promotion and prevention of: leishmaniasis, Hansen and Skin Cancer. I participated in writing theoretical contents, challengesand evaluations of the leishmaniasis virtual module focus in diagnosis and epidemiology and performing virtual teaching to students. Show less

  • Secretary of the Human Research Ethics Committee

    Sept 2012 - Mar 2013

  • Principal researcher scientist

    Jan 2007 - Dec 2012

  • Teacher of leishmaniasis virtual module

    Oct 2011 - Dec 2011
• 

  Fundación universitaria de ciencias de la salud – sociedad de cirugía de bogotá

  Mar 2013 - Oct 2014

  Knowledge manager

  . Consolidated the structure of the research process and raised productivity (# papers & studies) of the 32 research groups, leading teams of clinical-surgical specialties (+25), nursing, surgical instrumentation, psychology and administration to achieve recognition and classification process of COLCIENCIAS (reaching 22/32). . Achieved the first public-private alliance signed in the framework of management of knowledge that enabled engagement with key public institutions and opportunities to get new sources for research.. Engaged in the recognition of the FUCS as a center of health technology assessment and clinical practice guidelines for IETS with impact on health policy decisions at the national level. Show less

• 

  Roche colombia

  Oct 2014 - Aug 2020

  Lead the strategic framework in public policy, communications, digital transformation, corporate sustainability and market access, working with different stakeholders such as the national government, scientific societies, technical advisory/regulatory bodies, trade organizations, media and patient associations, among others, as an enabler to promote healthcare with quality and equity, and an effective and sustainable access to innovation.Catalyze the movement to a value-based negotiation model, generating a new approach of negotiation & access focus on addressing the achievement of health outcomes with sustainability building a solid value proposition of the health technologies and strategic areas through a holistic approach through the patient journey having in the center the customer needs. Show less Designed the market access area that leads the positioning strategic 100% of the Pharma portfolio, through a solid and comprehensive value proposition customer centric that includes: economic evidence, regulation, pricing strategy and innovative access models, stimulating teamwork with the entire company.Lead the promotion of opportunities for differentiation and generation of value for products through economic studies, value recognition strategies and innovative access models. Engagement and active work with different actors of the health system in the discussion of the public policies of coverage, financing, exclusions, inclusions, evaluation of health technologies, generation of evidence and pricing, as well as the construction of synergies with the Government, academia, insurers, providers, KOLs, TAEs and the pharmaceutical industry for the generation of public policies with national impact.Articulation and leadership of multidisciplinary teams to define the value proposition through the integration, articulation and transmission of the positive impact generated by brands and the company for patients, economy and society, to improve real and sustainable access for all Colombians to innovation. Show less Boosted the evidence generation strategy that strength patient access to the 100% of the Pharma portfolio as a value differential for the business, working closely with other Roche departments including public affairs, commercial, medical and access. Liaising and developing relationships with the Government, healthcare professionals, other key stakeholders (EPS, IPS). To demonstrate the value and contribute to the funding of products from the health economics perspective training , adaptation and / or development or validation of economic models, stakeholder´s relationship, innovator access esquemes, pricing analysis and value proposition, providing information for internal and external stakeholders in the context of Colombian health system and the global and local pharmaceutical market.• Biotechnology Strategy Leader (temporal) July – June 2016Main responsabilities were plan, execute and implement the biotechnology strategy of the company adjusted to the Colombian market. Show less

  • Corporate Affairs & Market Access director

    Apr 2019 - Aug 2020

  • Market Access Director

    Nov 2018 - Apr 2019

  • Market Access manager

    Nov 2017 - Nov 2018

  • Health Economics and value recognition manager

    Oct 2016 - Nov 2017

  • Health Economics Manager

    Oct 2014 - Oct 2016
• 

  Independent consultant

  Sept 2020 - Apr 2021

  Senior healthcare consultant

  Support market access training and strategies in the pharmaceutical sector using digital strategies, looking for enhancing capabilities in the team and building value based proposals to make the difference in high cost diseases competitive scenario.Advise a Pharma Trade Organization in value based access and reimbursement models in Colombia, doing a benchmark, diagnosis of strengths and weaknesses in public policy and execution environment in the country, create a pathway to leverage a successful implementation, make recommendations for pharma companies and perform a legal assessment that guides the action plan. Show less

• 

  Msd

  Apr 2021 - Jun 2021

  Policy, market access & external communications director, organon & co
• 

  Organon

  Jun 2021 - now

  *Responsible of generating a positive environment for the adoption of innovation and broad access for the company’s products to customers and patients. *Lead public and government affairs, corporate social responsibility, market access and external communications strategies.* Enhance company’s visibility and reputation working closely with key stakeholders, as well as developing strategic collaborations.* Shape the environment & market access strategy: pre-launch & post launch, strategic pricing, value and affordability, and establishing scientific and economical engagement with stakeholders. Show less

  • Policy, Access, ESG & External Communications Director LAMEX Cluster

    Jun 2024 - now

  • Policy, Access, ESG & External Communications Director LATAM Cluster

    Jan 2024 - May 2024

  • Policy, Access, ESG & External Communications Director Andean Cluster (Colombia, Perú & Ecuador)

    May 2022 - Mar 2024

  • Policy, Market Access & External Communications Director

    Jun 2021 - May 2022